Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia

Zaki, 2012, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia., N Engl J Med, 367, 1814, 10.1056/NEJMoa1211721

World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) [cited 2016 Jun 26]. http://www.who.int/emergencies/mers-cov/en/

Korea Centers for Disease Control and Prevention, 2015, Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015., Osong Public Health Res Perspect, 6, 269, 10.1016/j.phrp.2015.08.006

Public Health England, International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). Treatment of MERS-CoV: information for clinicians. Clinical decision-making support for treatment of MERS-CoV patients. V3.0 [cited 2016 Apr 29]. http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/459835/merscov_for_clinicians_sept2015.pdf

Hung, 2013, Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection., Chest, 144, 464, 10.1378/chest.12-2907

Stockman, 2006, SARS: systematic review of treatment effects., PLoS Med, 3, e343, 10.1371/journal.pmed.0030343

Hung, 2011, Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection., Clin Infect Dis, 52, 447, 10.1093/cid/ciq106

Luke, 2006, Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?, Ann Intern Med, 145, 599, 10.7326/0003-4819-145-8-200610170-00139

Cheng, 2005, Use of convalescent plasma therapy in SARS patients in Hong Kong., Eur J Clin Microbiol Infect Dis, 24, 44, 10.1007/s10096-004-1271-9

Kong, 2006, Successful treatment of avian influenza with convalescent plasma., Hong Kong Med J, 12, 489

Mair-Jenkins, 2015, The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis., J Infect Dis, 211, 80, 10.1093/infdis/jiu396

Zhao, 2015, Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection., J Virol, 89, 6117, 10.1128/JVI.00446-15

Arabi, 2015, Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol., Springerplus, 4, 709, 10.1186/s40064-015-1490-9

Centers for Disease Control and Prevention. CDC laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV) [cited 2015 Sep 22]. http://www.cdc.gov/coronavirus/MERS/lab/lab-testing.html

World Health Organization. Laboratory testing for Middle East respiratory syndrome coronavirus: interim recommendations (revised); September 2014 [cited 2015 Sep 22]. http://www.who.int/csr/disease/coronavirus_infections/WHO_interim_recommendations_lab_detection_MERSCoV_092014.pdf

Luke, 2016, Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo., Sci Transl Med, 8, 326ra21, 10.1126/scitranslmed.aaf1061

World Health Organization. Guidelines on assessing donor suitability for blood donation [cited 2015 Sep 22]. http://apps.who.int/iris/bitstream/10665/76724/1/9789241548519_eng.pdf?ua=1

WHO Blood Regulators Network (BRN). Position paper on collection and use of convalescent plasma or serum as an element in Middle East respiratory syndrome coronavirus response [cited 2015 Sep 22]. http://www.who.int/bloodproducts/brn/BRN_PositionPaperConvPlasmaMERSCoV_March2014.pdf

Corman, 2012, Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction., Euro Surveill, 17, 20285, 10.2807/ese.17.39.20285-en

Drosten, 2014, Transmission of MERS-coronavirus in household contacts., N Engl J Med, 371, 828, 10.1056/NEJMoa1405858

Müller, 2015, Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study., Lancet Infect Dis, 15, 559, 10.1016/S1473-3099(15)70090-3

Mou, 2013, The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies., J Virol, 87, 9379, 10.1128/JVI.01277-13

Chu, 2014, MERS coronaviruses in dromedary camels, Egypt., Emerg Infect Dis, 20, 1049, 10.3201/eid2006.140299

Gierer, 2013, Lack of MERS coronavirus neutralizing antibodies in humans, Eastern Province, Saudi Arabia., Emerg Infect Dis, 19, 2034, 10.3201/eid1912.130701

Aburizaiza, 2014, Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012., J Infect Dis, 209, 243, 10.1093/infdis/jit589

Memish ZA, Alsahly A, Masri MA, Heil GL, Anderson BD, Peiris M, Sparse evidence of MERS-CoV infection among animal workers living in southern Saudi Arabia during 2012. Influenza Other Respir Viruses. 2015;9:64–7. 10.1111/irv.1228725470665

Cao, 2007, Disappearance of antibodies to SARS-associated coronavirus after recovery., N Engl J Med, 357, 1162, 10.1056/NEJMc070348

Xie, 2005, Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge., Respir Res, 6, 5, 10.1186/1465-9921-6-5

Callow, 1990, The time course of the immune response to experimental coronavirus infection of man., Epidemiol Infect, 105, 435, 10.1017/S0950268800048019

Alagaili, 2014, Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia., MBio, 5, e00884, 10.1128/mBio.01002-14

The Wall Street Journal. South Korea tries old weapon to fight MERS [cited 2015 Sep 22]. http://www.wsj.com/articles/south-korea-tries-old-weapon-to-fight-mers-1434451587

Pascal, 2015, Pre- and postexposure efficacy of fully human antibodies against spike protein in a novel humanized mouse model of MERS-CoV infection., Proc Natl Acad Sci U S A, 112, 8738, 10.1073/pnas.1510830112